Paysign holder plans 150K-share, $1.95M sale

Rule 144 filing covers a planned resale of 150,000 Paysign common shares tied to the Gamma Innovations, LLC acquisition.

Available on EDGAR 09/08/2026 - 03:18 PM EDT Accepted by SEC EDGAR 09/08/2026 - 03:18 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Paysign, Inc. (PAYS) received a Rule 144 notice indicating an intended sale of its common stock. The notice covers up to 150,000 shares of Paysign common stock, with an aggregate market value of $1,950,000, to be sold through Merrill Lynch, Pierce, Fenner & Smith on Nasdaq. The shares are to be sold for the account of Michael C. Ngo, with a remark that the sale is on behalf of Gamma Innovations LLC. The securities relate to 1,000,000 shares of Paysign common stock originally received as consideration in the acquisition of Gamma Innovations, LLC.

Key Figures

Shares to be sold under Rule 144: 150,000 shares Aggregate market value of shares to be sold: $1,950,000 Shares outstanding: 56,462,156 shares +3 more

6 metrics

Shares to be sold under Rule 144 150,000 shares Common stock covered by the notice for sale on Nasdaq

Aggregate market value of shares to be sold $1,950,000 Aggregate market value of the 150,000 Paysign common shares

Shares outstanding 56,462,156 shares Paysign common shares outstanding referenced in the Rule 144 notice

Shares received in acquisition 1,000,000 shares Paysign common stock received as consideration for acquisition of Gamma Innovations, LLC

Date shares received August 12, 2025 Date 1,000,000 Paysign shares were received in the Gamma Innovations, LLC acquisition

Date of Rule 144 notice September 8, 2026 Date on which the Form 144 notice was signed and dated

Key Terms

Rule 144, affiliate, aggregate market value, consideration for acquisition

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

affiliate regulatory

"In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice. affiliate"

aggregate market value financial

"Common | Merrill Lynch Pierce Fenner & Smith ... | 150000 | 1950000 |"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

consideration for acquisition financial

"1000000 | 08/12/2025 | Consideration for acquisition of Gamma Innovations, LLC"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for Paysign (PAYS)?

It discloses an intended sale of up to 150,000 shares of Paysign common stock, with an aggregate market value of $1,950,000, to be sold on Nasdaq under Rule 144 for the account of Michael C. Ngo.

Who is involved in the planned Paysign (PAYS) share sale under Form 144?

The planned sale is for the account of Michael C. Ngo, with a remark that it is a sale on behalf of Gamma Innovations LLC. The broker listed is Merrill Lynch, Pierce, Fenner & Smith on Nasdaq.

How many Paysign (PAYS) shares are covered by this Rule 144 notice?

The notice covers up to 150,000 shares of Paysign common stock, with an aggregate market value of $1,950,000. Paysign reports 56,462,156 shares of common stock outstanding in connection with this notice.

What is the origin of the Paysign (PAYS) shares to be sold?

The filing states that 1,000,000 shares of Paysign common stock were received on August 12, 2025 as consideration for the acquisition of Gamma Innovations, LLC. The planned Rule 144 sale relates to these securities.

On what date is the Paysign (PAYS) Rule 144 notice dated?

The date of notice is stated as September 8, 2026. The securities table also lists September 8, 2026 in connection with the planned sale of the 150,000 shares on Nasdaq.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002135448
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Paysign
SEC File Number	001-38623
Address of Issuer	2615 St. Rose Parkway Henderson NEVADA 89052
Phone	7024532221
Name of Person for Whose Account the Securities are To Be Sold	Michael C Ngo
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	affiliate

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch Pierce Fenner & Smith 724 W Lancaster Ave. Wayne PA 19087	150000	1950000	56462156	09/08/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/12/2025	Shares received in acquisition	Gamma Innovations, LLC			1000000	08/12/2025	Consideration for acquisition of Gamma Innovations, LLC

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Sale on behalf of Gamma Innovations LLC
Date of Notice	09/08/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Michael C Ngo
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)